Skip to main content

Table 2 Results of national post-market surveillance assay in veterinary medicines from 2006 to 2016

From: National post-market surveillance assessment of veterinary medicines in Korea during the past decade

Year

Antibiotics

OCDa

Biologics

Total

Testedb

Noncompliant (%)c

Testedb

Noncompliant (%)c

Testedb

Noncompliant (%)c

Testedb

Noncompliant (%)c

2006

606

23 (3.8)

863

24 (2.8)

63

0 (0.0)

1532

47 (3.1)

2007

771

23 (3.0)

687

26 (3.8)

50

0 (0.0)

1508

49 (3.2)

2008

782

5 (0.6)

756

19 (2.5)

45

1 (2.2)

1583

25 (1.6)

2009

916

15 (1.6)

816

43 (5.3)

103

1 (1.0)

1835

59 (3.2)

2010

934

10 (1.1)

663

35 (5.3)

61

1 (1.6)

1658

46 (2.8)

2011

881

17 (1.9)

759

30 (4.0)

55

0 (0.0)

1695

47 (2.8)

2012

918

2 (0.2)

721

22 (3.1)

47

0 (0.0)

1686

24 (1.4)

2013

932

2 (0.2)

664

13 (2.0)

54

1 (1.9)

1650

16 (1.0)

2014

889

4 (0.4)

707

22 (3.1)

70

3 (4.3)

1666

29 (1.7)

2015

1039

1 (0.1)

680

14 (2.1)

24

0 (0.0)

1743

15 (0.9)

2016

836

1 (0.1)

821

0 (0.0)

0

0 (0.0)

1657

1 (0.1)

Total

9504

103 (1.1)

8137

248 (3.0)

572

7 (1.2)

18,213

358 (2.0)

  1. aOther chemical drugs except antibiotics (OCD)
  2. bThe number of tested in the national post-market surveillance assay
  3. cThe rate of non compliant products, (%) in the national post-market surveillance assay